The reactive stroma microenvironment and prostate cancer progression

Endocrine-Related Cancer

Volumn 19, Issue 6, 2012, Pages

  Barron, David A ^a   Rowley, David R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; INTERLEUKIN 8; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; WNT1 PROTEIN;

ANGIOGENESIS; CANCER GROWTH; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; EPITHELIUM CELL; HOMEOSTASIS; HUMAN; MESENCHYME CELL; METASTASIS; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STROMA; STROMA CELL; TUMOR MICROENVIRONMENT; WOUND HEALING;

ANIMALS; DISEASE PROGRESSION; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA; TUMOR MICROENVIRONMENT;

EID: 84869223265     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-12-0085     Document Type: Review

References (160)

1. Abe R, Donnelly SC, Peng T, Bucala R & Metz CN 2001 Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. Journal of Immunology 166 7556-7562. (Pubitemid 32525636)
2. Ahmed A 1990 The myofibroblast in breast disease. Pathology Annual 25 237-286.
3. Almeida-Porada G, Zanjani ED & Porada CD 2010 Bone marrow stem cells and liver regeneration. Experimental Hematology 38 574-580. (doi:10.1016/j. exphem.2010.04.007)
4. Alonso-Magdalena P, Brossner C, Reiner A, Cheng G, Sugiyama N, Warner M & Gustafsson JA 2009 A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia. PNAS 106 2859-2863. (doi:10.1073/pnas.0812666106)
5. Ao M, Williams K, Bhowmick NA & Hayward SW 2006 Transforming growth factor-β promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. Cancer Research 66 8007-8016. (doi:10.1158/0008- 5472.CAN-05-4451)
6. Ao M, Franco OE, Park D, Raman D, Williams K & Hayward SW 2007 Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Research 67 4244-4253. (doi:10.1158/0008-5472.CAN-06-3946)
7. Ayala AG & Ro JY 2007 Prostatic intraepithelial neoplasia: recent advances. Archives of Pathology & Laboratory Medicine 131 1257-1266. (Pubitemid 47257638)
8. Ayala G, Tuxhorn JA, Wheeler TM, Frolov A, Scardino PT, Ohori M, Wheeler M, Spitler J & Rowley DR 2003 Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer. Clinical Cancer Research 9 4792-4801. (Pubitemid 37323282)
9. Ayala GE, Dai H, Powell M, Li R, Ding Y, Wheeler TM, Shine D, Kadmon D, Thompson T, Miles BJ et al. 2008 Cancer-related axonogenesis and neurogenesis in prostate cancer. Clinical Cancer Research 14 7593-7603. (doi:10.1158/1078-0432. CCR-08-1164)
10. Barron DA, Strand DW, Ressler SJ, Dang TD, Hayward SW, Yang F, Ayala GE, Ittmann M & Rowley DR 2010 TGF-β1 induces an age-dependent inflammation of nerve ganglia and fibroplasia in the prostate gland stroma of a novel transgenic mouse. PLoS ONE 5 e13751. (doi:10.1371/journal.pone.0013751)
11. Barsky SH, Green WR, Grotendorst GR & Liotta LA 1984 Desmoplastic breast carcinoma as a source of human myofibroblasts. American Journal of Pathology 115 329-333. (Pubitemid 14121182)
12. Basanta D, Strand DW, Lukner RB, Franco OE, Cliffel DE, Ayala GE, Hayward SW & Anderson AR 2009 The role of transforming growth factor-β- mediated tumor-stroma interactions in prostate cancer progression: an integrative approach. Cancer Research 69 7111-7120. (doi:10.1158/0008-5472.CAN- 08-3957)
13. Basanta D, Scott JG, Fishman MN, Ayala G, Hayward SW & Anderson AR 2012 Investigating prostate cancer tumour-stroma interactions: clinical and biological insights from an evolutionary game. British Journal of Cancer 106 174-181. (doi:10.1038/bjc.2011.517)
14. Bentzon JF, Weile C, Sondergaard CS, Hindkjaer J, Kassem M & Falk E 2006 Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice. Arteriosclerosis, Thrombosis, and Vascular Biology 26 2696-2702. (doi:10.1161/01.ATV.0000247243. 48542.9d)
15. Bettendorf O, Schmidt H, Staebler A, Grobholz R, Heinecke A, Boecker W, Hertle L & Semjonow A 2008 Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate. Genes, Chromosomes & Cancer 47 565-572. (doi:10.1002/gcc.20560)
16. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG & Moses HL 2004 TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303 848-851. (doi:10.1126/science.1090922)
17. Bierie B & Moses HL 2006 Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer. Nature Reviews. Cancer 6 506-520. (doi:10.1038/nrc1926)
18. Bierie B & Moses HL 2010 Transforming growth factor β (TGF-β) and inflammation in cancer. Cytokine & Growth Factor Reviews 21 49-59. (doi:10.1016/j.cytogfr.2009.11.008)
19. Brandes ME, Mai UE, Ohura K & Wahl SM 1991 Type I transforming growth factor-β receptors on neutrophils mediate chemotaxis to transforming growth factor-β. Journal of Immunology 147 1600-1606.
20. Brittan M, Hunt T, Jeffery R, Poulsom R, Forbes SJ, Hodivala-Dilke K, Goldman J, Alison MR & Wright NA 2002 Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut 50 752-757. (doi:10.1136/gut.50.6.752)
21. Brown RD, Ambler SK, Mitchell MD & Long CS 2005 The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annual Review of Pharmacology and Toxicology 45 657-687. (doi:10.1146/annurev.pharmtox. 45.120403.095802)
22. Bucala R, Spiegel LA, Chesney J, Hogan M & Cerami A 1994 Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Molecular Medicine 1 71-81.
23. Campbell JH, Efendy JL, Han C, Girjes AA & Campbell GR 2000 Haemopoietic origin of myofibroblasts formed in the peritoneal cavity in response to a foreign body. Journal of Vascular Research 37 364-371. (doi:10.1159/000025752)
24. Colvin GA, Lambert JF, Moore BE, Carlson JE, Dooner MS, Abedi M, Cerny J & Quesenberry PJ 2004 Intrinsic hematopoietic stem cell/progenitor plasticity: inversions. Journal of Cellular Physiology 199 20-31. (doi:10.1002/jcp.10436)
25. Condeelis J & Pollard JW 2006 Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124 263-266. (doi:10.1016/j.cell.2006.01.007)
26. Cornell RJ, Rowley D, Wheeler T, Ali N & Ayala G 2003 Neuroepithelial interactions in prostate cancer are enhanced in the presence of prostatic stroma. Urology 61 870-875. (doi:10.1016/S0090-4295(02)02426-3)
27. Coussens LM & Werb Z 2002 Inflammation and cancer. Nature 420 860-867. (doi:10.1038/nature01322)
28. Cunha GR, Hayward SW & Wang YZ 2002 Role of stroma in carcinogenesis of the prostate. Differentiation 70 473-485. (doi:10.1046/j.1432-0436.2002. 700902.x)
29. Cunha GR, Hayward SW, Wang YZ & Ricke WA 2003 Role of the stromal microenvironment in carcinogenesis of the prostate. International Journal of Cancer 107 1-10. (doi:10.1002/ijc.11335)
30. Dakhova O, Ozen M, Creighton CJ, Li R, Ayala G, Rowley D & Ittmann M 2009 Global gene expression analysis of reactive stroma in prostate cancer. Clinical Cancer Research 15 3979-3989. (doi:10.1158/1078-0432.CCR-08-1899)
31. De Marzo AM, Meeker AK, Zha S, Luo J, Nakayama M, Platz EA, Isaacs WB & Nelson WG 2003 Human prostate cancer precursors and pathobiology. Urology 62 55-62. (doi:10.1016/j.urology.2003.09.053)
32. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, Nakai Y, Isaacs WB & Nelson WG 2007 Inflammation in prostate carcinogenesis. Nature Reviews. Cancer 7 256-269. (doi:10.1038/nrc2090)
33. DeNardo DG, Barreto JB, Andreu P, Vasquez L, Tawfik D, Kolhatkar N & Coussens LM 2009 CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16 91-102. (doi:10.1016/j.ccr.2009.06.018)
34. Derynck R, Akhurst RJ & Balmain A 2001 TGF-b signaling in tumor suppression and cancer progression. Nature Genetics 29 117-129. (doi:10.1038/ng1001-117)
35. Desmouliere A, Darby IA & Gabbiani G 2003 Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Laboratory Investigation 83 1689-1707. (doi:10.1097/01.LAB. 0000101911.53973.90)
36. Desmouliere A, Chaponnier C & Gabbiani G 2005 Tissue repair, contraction, and the myofibroblast. Wound Repair and Regeneration 13 7-12. (doi:10.1111/j.1067-1927.2005.130102.x)
37. Dimanche-Boitrel MT, Vakaet L Jr, Pujuguet P, Chauffert B, Martin MS, Hammann A, Van Roy F, Mareel M & Martin F 1994 In vivo and in vitro invasiveness of a rat colon-cancer cell line maintaining E-cadherin expression: an enhancing role of tumor-associated myofibroblasts. International Journal of Cancer 56 512-521. (doi:10.1002/ijc.2910560410)
38. Direkze NC, Forbes SJ, Brittan M, Hunt T, Jeffery R, Preston SL, Poulsom R, Hodivala-Dilke K, Alison MR & Wright NA 2003 Multiple organ engraftment by bone-marrow-derived myofibroblasts and fibroblasts in bone-marrow- transplanted mice. Stem Cells 21 514-520. (doi:10.1634/stemcells.21-5-514)
39. Di Vizio D, Kim J, Hager MH, Morello M, Yang W, Lafargue CJ, True LD, Rubin MA, Adam RM, Beroukhim R et al. 2009 Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Research 69 5601-5609. (doi:10.1158/0008-5472.CAN-08-3860)
40. Dvorak HF 1986 Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. New England Journal of Medicine 315 1650-1659. (doi:10.1056/NEJM198612253152606)
41. El-Alfy M, Pelletier G, Hermo LS & Labrie F 2000 Unique features of the basal cells of human prostate epithelium. Microscopic Research and Technique 51 436-446. (doi:10.1002/1097-0029(20001201)51:5〈436::AID-JEMT6〉3.0. CO;2-T)
42. Epperly MW, Guo H, Gretton JE & Greenberger JS 2003 Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. American Journal of Respiratory Cell and Molecular Biology 29 213-224. (doi:10.1165/rcmb.2002- 0069OC)
43. Epstein JI 2004 Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy. Modern Pathology 17 307-315. (doi:10.1038/modpathol. 3800050)
44. Epstein JI 2009 Precursor lesions to prostatic adenocarcinoma. Virchows Archiv 454 1-16. (doi:10.1007/s00428-008-0707-5)
45. Eyden B, Banerjee SS, Shenjere P & Fisher C 2009 The myofibroblast and its tumours. Journal of Clinical Pathology 62 236-249. (doi:10.1136/jcp. 2008.061630)
46. Folkman J 1971 Tumor angiogenesis: therapeutic implications. New England Journal of Medicine 285 1182-1186. (doi:10.1056/NEJM197108122850711)
47. Forbes SJ, Russo FP, Rey V, Burra P, Rugge M, Wright NA & Alison MR 2004 A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 126 955-963. (doi:10.1053/j.gastro.2004. 02.025)
48. Franco OE, Shaw AK, Strand DW & Hayward SW 2010 Cancer associated fibroblasts in cancer pathogenesis. Seminars in Cell and Developmental Biology 21 33-39. (doi:10.1016/j.semcdb.2009.10.010)
49. Franco OE, Jiang M, Strand DW, Peacock J, Fernandez S, Jackson RS II, Revelo MP, Bhowmick NA & Hayward SW 2011 Altered TGF-β signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis. Cancer Research 71 1272-1281. (doi:10.1158/0008-5472.CAN-10-3142)
50. Gabbiani G 2003 The myofibroblast in wound healing and fibrocontractive diseases. Journal of Pathology 200 500-503. (doi:10.1002/path.1427)
51. Gabbiani G, Ryan GB & Majne G 1971 Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 27 549-550. (doi:10.1007/BF02147594)
52. Gann PH, Klein KG, Chatterton RT, Ellman AE, Grayhack JT, Nadler RB & Lee C 1999 Growth factors in expressed prostatic fluid from men with prostate cancer, BPH, and clinically normal prostates. Prostate 40 248-255. (doi:10.1002/(SICI)1097-0045(19990901)40:4〈248::AID-PROS6〉3.0.CO;2-M)
53. Gerdes MJ, Dang TD, Larsen M & Rowley DR 1998 Transforming growth factor-b1 induces nuclear to cytoplasmic distribution of androgen receptor and inhibits androgen response in prostate smooth muscle cells. Endocrinology 139 3569-3577. (doi:10.1210/en.139.8.3569)
54. Gerdes MJ, Larsen M, Dang TD, Ressler SJ, Tuxhorn JA & Rowley DR 2004 Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF-β1. Prostate 58 299-307. (doi:10.1002/pros.10327)
55. Gordon S & Taylor PR 2005 Monocyte and macrophage heterogeneity. Nature Reviews. Immunology 5 953-964. (doi:10.1038/nri1733)
56. Grompe M 2003 The role of bone marrow stem cells in liver regeneration. Seminars in Liver Disease 23 363-372. (doi:10.1055/s-2004-815560)
57. Hanahan D & Weinberg RA 2000 The hallmarks of cancer. Cell 100 57-70. (doi:10.1016/S0092-8674(00)81683-9)
58. Hanahan D & Weinberg RA 2011 Hallmarks of cancer: the next generation. Cell 144 646-674. (doi:10.1016/j.cell.2011.02.013)
59. Hao H, Gabbiani G, Camenzind E, Bacchetta M, Virmani R & Bochaton-Piallat ML 2006 Phenotypic modulation of intima and media smooth muscle cells in fatal cases of coronary artery lesion. Arteriosclerosis, Thrombosis, and Vascular Biology 26 326-332. (doi:10.1161/01.ATV.0000199393.74656.4c)
60. Haudek SB, Xia Y, Huebener P, Lee JM, Carlson S, Crawford JR, Pilling D, Gomer RH, Trial J, Frangogiannis NG et al. 2006 Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. PNAS 103 18284-18289. (doi:10.1073/pnas.0608799103)
61. Hayward SW, Wang Y, Cao M, Hom YK, Zhang B, Grossfeld GD, Sudilovsky D & Cunha GR 2001 Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Research 61 8135-8142. (Pubitemid 33091604)
62. Heike T & Nakahata T 2004 Stem cell plasticity in the hematopoietic system. International Journal of Hematology 79 7-14. (doi:10.1007/BF02983527)
63. Hinz B 2007 Formation and function of the myofibroblast during tissue repair. Journal of Investigative Dermatology 127 526-537. (doi:10.1038/sj.jid. 5700613)
64. Hirschel BJ, Gabbiani G, Ryan GB & Majno G 1971 Fibroblasts of granulation tissue: immunofluorescent staining with antismooth muscle serum. Proceedings of the Society for Experimental Biology and Medicine 138 466-469.
65. Hoofnagle MH, Wamhoff BR & Owens GK 2004 Lost in transdifferentiation. Journal of Clinical Investigation 113 1249-1251. (doi:10.1172/JCI21761)
66. Hoofnagle MH, Thomas JA, Wamhoff BR & Owens GK 2006 Origin of neointimal smooth muscle: we've come full circle. Arteriosclerosis, Thrombosis, and Vascular Biology 26 2579-2581. (doi:10.1161/01.ATV.0000249623.79871.bc)
67. Hu B, Gharaee-Kermani M, Wu Z & Phan SH 2010 Epigenetic regulation of myofibroblast differentiation by DNA methylation. American Journal of Pathology 177 21-28. (doi:10.2353/ajpath.2010.090999)
68. Ishii G, Sangai T, Oda T, Aoyagi Y, Hasebe T, Kanomata N, Endoh Y, Okumura C, Okuhara Y, Magae J et al. 2003 Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochemical and Biophysical Research Communications 309 232-240. (doi:10.1016/S0006-291X(03)01544-4)
69. Jagadeesan J & Bayat A 2007 Transforming growth factor β (TGFβ) and keloid disease. International Journal of Surgery 5 278-285. (doi:10.1016/j.ijsu.2006.04.007)
70. Jones E, Pu H & Kyprianou N 2009 Targeting TGF-β in prostate cancer: therapeutic possibilities during tumor progression. Expert Opinion on Therapeutic Targets 13 227-234. (doi:10.1517/14728220802705696)
71. Kalluri R 2003 Basement membranes: structure, assembly and role in tumour angiogenesis. Nature Reviews. Cancer 3 422-433. (doi:10.1038/nrc1094)
72. Kalluri R 2009 EMT: when epithelial cells decide to become mesenchymal-like cells. Journal of Clinical Investigation 119 1417-1419. (doi:10.1172/JCI39675)
73. Kalluri R & Han Y 2008 Targeting TGF-β and the extracellular matrix in Marfan's syndrome. Developmental Cell 15 1-2. (doi:10.1016/j.devcel. 2008.06.005)
74. Kalluri R & Neilson EG 2003 Epithelial-mesenchymal transition and its implications for fibrosis. Journal of Clinical Investigation 112 1776-1784. (doi:10.1172/JCI20530)
75. Kalluri R & Weinberg RA 2009 The basics of epithelial-mesenchymal transition. Journal of Clinical Investigation 119 1420-1428. (doi:10.1172/JCI39104)
76. Kaminski A, Hahne JC, Haddouti el M, Florin A, Wellmann A & Wernert N 2006 Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts. International Journal of Molecular Medicine 18 941-950.
77. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS & Ferrara N 1993 Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362 841-844. (doi:10.1038/362841a0)
78. Kiskowski MA, Jackson RS II, Banerjee J, Li X, Kang M, Iturregui JM, Franco OE, Hayward SW & Bhowmick NA 2011 Role for stromal heterogeneity in prostate tumorigenesis. Cancer Research 71 3459-3470. (doi:10.1158/0008-5472. CAN-10-2999)
79. Kojima Y, Acar A, Eaton EN, Mellody KT, Scheel C, Ben-Porath I, Onder TT, Wang ZC, Richardson AL, Weinberg RA et al. 2010 Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. PNAS 107 20009-20014. (doi:10.1073/pnas.1013805107)
80. Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, Bottinger EP, Klotman PE & Thorgeirsson SS 1996 Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease. Laboratory Investigation 74 991-1003. (Pubitemid 26182412)
81. Li H, Fan X & Houghton J 2007 Tumor microenvironment: the role of the tumor stroma in cancer. Journal of Cellular Biochemistry 101 805-815. (doi:10.1002/jcb.21159)
82. Li X, Placencio V, Iturregui JM, Uwamariya C, Sharif-Afshar AR, Koyama T, Hayward SW & Bhowmick NA 2008 Prostate tumor progression is mediated by a paracrine TGF-β/Wnt3a signaling axis. Oncogene 27 7118-7130. (doi:10.1038/onc.2008.293)
83. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K, Stadtfeld M, Yachechko R, Tchieu J, Jaenisch R et al. 2007 Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1 55-70. (doi:10.1016/j.stem.2007.05.014)
84. Menke A & Adler G 2002 TGFβ-induced fibrogenesis of the pancreas. International Journal of Gastrointestinal Cancer 31 41-46. (doi:10.1385/IJGC:31:1-3:41)
85. Metz CN 2003 Fibrocytes: a unique cell population implicated in wound healing. Cellular and Molecular Life Sciences 60 1342-1350. (doi:10.1007/s00018- 003-2328-0)
86. Mueller MM & Fusenig NE 2004 Friends or foes - bipolar effects of the tumour stroma in cancer. Nature Reviews. Cancer 4 839-849. (doi:10.1038/ nrc1477)
87. Nataraj D, Ernst A & Kalluri R 2010 Idiopathic pulmonary fibrosis is associated with endothelial to mesenchymal transition. American Journal of Respiratory Cell and Molecular Biology 43 129-130. (doi:10.1165/rcmb.2010- 0044ED)
88. Nelson WG, De Marzo AM, De Weese TL & Isaacs WB 2004 The role of inflammation in the pathogenesis of prostate cancer. Journal of Urology 172 S6-S11 (discussion S11-12). (doi:10.1097/01.ju.0000142058.99614.ff)
89. Ogawa M 2010 Hematopoietic stem cell plasticity. Introduction. Experimental Hematology 38 527-528. (doi:10.1016/j.exphem.2010.04.009)
90. Olaso E, Santisteban A, Bidaurrazaga J, Gressner AM, Rosenbaum J & Vidal-Vanaclocha F 1997 Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology 26 634-642. (doi:10.1002/hep.510260315)
91. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD & Cunha GR 1999 Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Research 59 5002-5011. (Pubitemid 29472907)
92. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL & Weinberg RA 2005 Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121 335-348. (doi:10.1016/j.cell.2005.02. 034)
93. Peehl DM & Sellers RG 1997 Induction of smooth muscle cell phenotype in cultured human prostatic stromal cells. Experimental Cell Research 232 208-215. (doi:10.1006/excr.1997.3525)
94. Peehl DM & Sellers RG 2000 Cultured stromal cells: an in vitro model of prostatic mesenchymal biology. Prostate 45 115-123. (doi:10.1002/1097- 0045(20001001)45:2〈115::AID-PROS5〉3.0.CO;2-C)
95. Placencio VR, Sharif-Afshar AR, Li X, Huang H, Uwamariya C, Neilson EG, Shen MM, Matusik RJ, Hayward SW & Bhowmick NA 2008 Stromal transforming growth factor-β signaling mediates prostatic response to androgen ablation by paracrine Wnt activity. Cancer Research 68 4709-4718. (doi:10.1158/0008-5472. CAN-07-6289)
96. Placencio VR, Li X, Sherrill TP, Fritz G & Bhowmick NA 2010 Bone marrow derived mesenchymal stem cells incorporate into the prostate during regrowth. PLoS ONE 5 e12920. (doi:10.1371/journal.pone.0012920)
97. Pollard JW 2004 Tumour-educated macrophages promote tumour progression and metastasis. Nature Reviews. Cancer 4 71-78. (doi:10.1038/nrc1256)
98. Pollard JW 2009 Trophic macrophages in development and disease. Nature Reviews. Immunology 9 259-270. (doi:10.1038/nri2528)
99. Potenta S, Zeisberg E & Kalluri R 2008 The role of endothelial-to-mesenchymal transition in cancer progression. British Journal of Cancer 99 1375-1379. (doi:10.1038/sj.bjc.6604662)
100. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI & West AB 1999 Myofibroblasts I. Paracrine cells important in health and disease. American Journal of Physiology 277 C1-C9.
101. Prud'homme GJ 2007 Pathobiology of transforming growth factor β in cancer, fibrosis and immunologic disease, and therapeutic considerations. Laboratory Investigation 87 1077-1091. (doi:10.1038/labinvest.3700669)
102. Qian BZ & Pollard JW 2010 Macrophage diversity enhances tumor progression and metastasis. Cell 141 39-51. (doi:10.1016/j.cell.2010.03.014)
103. Quan TE, Cowper S, Wu SP, Bockenstedt LK & Bucala R 2004 Circulating fibrocytes: collagen-secreting cells of the peripheral blood. International Journal of Biochemistry and Cell Biology 36 598-606. (doi:10.1016/j.biocel.2003. 10.005)
104. Quesenberry PJ, Dooner MS & Aliotta JM 2010 Stem cell plasticity revisited: the continuum marrow model and phenotypic changes mediated by microvesicles. Experimental Hematology 38 581-592. (doi:10.1016/j.exphem.2010. 03.021)
105. Rajkumar VS, Howell K, Csiszar K, Denton CP, Black CM & Abraham DJ 2005 Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis. Arthritis Research & Therapy 7 R1113-R1123. (doi:10.1186/ar1790)
106. Richardson AM, Woodson K, Wang Y, Rodriguez-Canales J, Erickson HS, Tangrea MA, Novakovic K, Gonzalez S, Velasco A, Kawasaki ES et al. 2007 Global expression analysis of prostate cancer-associated stroma and epithelia. Diagnostic Molecular Pathology 16 189-197. (doi:10.1097/PDM.0b013e3180de20ac)
107. Roberts AB & Sporn MB 1996 Transforming growth factor-b. In The Molecular and Cellular Biology of Wound Repair, pp 275-308. Ed RAF Clark. New York, NY: Plenum Press.
108. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH et al. 1986 Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. PNAS 83 4167-4171. (doi:10.1073/pnas.83.12.4167)
109. Rodriguez-Canales J, Hanson JC, Tangrea MA, Erickson HS, Albert PS, Wallis BS, Richardson AM, Pinto PA, Linehan WM, Gillespie JW et al. 2007 Identification of a unique epigenetic sub-microenvironment in prostate cancer. Journal of Pathology 211 410-419. (doi:10.1002/path.2133)
110. Ronnov-Jessen L & Petersen OW 1993 Induction of α-smooth muscle actin by transforming growth factor-β1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Laboratory Investigation 68 696-707. (Pubitemid 23202798)
111. Ronnov-Jessen L, Petersen OW, Koteliansky VE & Bissell MJ 1995 The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. Journal of Clinical Investigation 95 859-873. (doi:10.1172/JCI117736)
112. Ronnov-Jessen L, Petersen OW & Bissell MJ 1996 Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiological Reviews 76 69-125. (Pubitemid 26048279)
113. Rowley DR 1998 What might a stromal response mean to prostate cancer progression? Cancer Metastasis Reviews 17 411-419. (doi:10.1023/A:1006129420005)
114. Ruffell B, DeNardo DG, Affara NI & Coussens LM 2010 Lymphocytes in cancer development: polarization towards pro-tumor immunity. Cytokine & Growth Factor Reviews 21 3-10. (doi:10.1016/j.cytogfr.2009.11.002)
115. Salm SN, Burger PE, Coetzee S, Goto K, Moscatelli D & Wilson EL 2005 TGF-β maintains dormancy of prostatic stem cells in the proximal region of ducts. Journal of Cell Biology 170 81-90. (doi:10.1083/jcb.200412015)
116. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB & Thorgeirsson SS 1995 Hepatic expression of mature transforming growth factor β1 in transgenic mice results in multiple tissue lesions. PNAS 92 2572-2576. (doi:10.1073/pnas.92.7.2572)
117. Sanvito F, Nichols A, Herrera PL, Huarte J, Wohlwend A, Vassalli JD & Orci L 1995 TGF-β1 overexpression in murine pancreas induces chronic pancreatitis and, together with TNF-α, triggers insulin-dependent diabetes. Biochemical and Biophysical Research Communications 217 1279-1286. (doi:10.1006/bbrc.1995.2906)
118. Schauer IG & Rowley DR 2011 The functional role of reactive stroma in benign prostatic hyperplasia. Differentiation 82 200-210. (doi:10.1016/j.diff. 2011.05.007)
119. Schauer IG, Ressler SJ, Tuxhorn JA, Dang TD & Rowley DR 2008 Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia. Urology 72 205-213. (doi:10.1016/j. urology.2007.11.083)
120. Schauer IG, Ressler SJ & Rowley DR 2009 Keratinocyte-derived chemokine induces prostate epithelial hyperplasia and reactive stroma in a novel transgenic mouse model. Prostate 69 373-384. (doi:10.1002/pros.20886)
121. Schmidt M, Sun G, Stacey MA, Mori L & Mattoli S 2003 Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. Journal of Immunology 171 380-389. (Pubitemid 36745311)
122. + monocytes. Experimental Hematology 38 557-563. (doi:10.1016/j.exphem.2010.03.015)
123. Sheffer Y, Leon O, Pinthus JH, Nagler A, Mor Y, Genin O, Iluz M, Kawada N, Yoshizato K & Pines M 2007 Inhibition of fibroblast to myofibroblast transition by halofuginone contributes to the chemotherapy-mediated antitumoral effect. Molecular Cancer Therapeutics 6 570-577. (doi:10.1158/1535-7163.MCT-06- 0468)
124. Shoskes DA, Albakri Q, Thomas K & Cook D 2002 Cytokine polymorphisms in men with chronic prostatitis/chronic pelvic pain syndrome: association with diagnosis and treatment response. Journal of Urology 168 331-335. (doi:10.1016/S0022-5347(05)64916-6)
125. Siegel PM & Massague J 2003 Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nature Reviews. Cancer 3 807-821. (doi:10.1038/nrc1208)
126. Singh H, Dang TD, Ayala GE & Rowley DR 2004 Transforming growth factor-β1 induced myofibroblasts regulate LNCaP cell death. Journal of Urology 172 2421-2425. (doi:10.1097/01.ju.0000138082.68045.48)
127. Sporn MB & Roberts AB 1988 Peptide growth factors are multifunctional. Nature 332 217-219. (doi:10.1038/332217a0)
128. Stover DG, Bierie B & Moses HL 2007 A delicate balance: TGF-β and the tumor microenvironment. Journal of Cellular Biochemistry 101 851-861. (doi:10.1002/jcb.21149)
129. Suga H, Matsumoto D, Eto H, Inoue K, Aoi N, Kato H, Araki J & Yoshimura K 2009 Functional implications of CD34 expression in human adipose-derived stem/progenitor cells. Stem Cells and Development 18 1201-1210. (doi:10.1089/scd.2009.0003)
130. Sugimoto H, Mundel TM, Kieran MW & Kalluri R 2006 Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biology & Therapy 5 1640-1646. (doi:10.4161/cbt.5.12.3354)
131. Tanner MJ, Welliver RC Jr, Chen M, Shtutman M, Godoy A, Smith G, Mian BM & Buttyan R 2011 Effects of androgen receptor and androgen on gene expression in prostate stromal fibroblasts and paracrine signaling to prostate cancer cells. PLoS ONE 6 e16027. (doi:10.1371/journal.pone.0016027)
132. Traktuev DO, Merfeld-Clauss S, Li J, Kolonin M, Arap W, Pasqualini R, Johnstone BH & March KL 2008 A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circulation Research 102 77-85. (doi:10.1161/CIRCRESAHA.107.159475)
133. Treves AJ 1984 The origin of monocyte-macrophage heterogeneity: possible alternatives. Medical Hypotheses 14 335-346. (doi:10.1016/0306-9877(84)90138-5)
134. True LD, Zhang H, Ye M, Huang CY, Nelson PS, von Haller PD, Tjoelker LW, Kim JS, Qian WJ, Smith RD et al. 2010 CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker. Modern Pathology 23 1346-1356. (doi:10.1038/modpathol.2010.122)
135. Tuxhorn JA, Ayala GE & Rowley DR 2001 Reactive stroma in prostate cancer progression. Journal of Urology 166 2472-2483. (doi:10.1016/S0022- 5347(05)65620-0)
136. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD & Rowley DR 2002a Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clinical Cancer Research 8 2912-2923. (Pubitemid 35025739)
137. Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE & Rowley DR 2002b Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Research 62 3298-3307. (Pubitemid 34602428)
138. Tuxhorn JA, McAlhany SJ, Yang F, Dang TD & Rowley DR 2002c Inhibition of transforming growth factor-β activity decreases angiogenesis in a human prostate cancerreactive stroma xenograft model. Cancer Research 62 6021-6025. (Pubitemid 35244446)
139. Vanpoucke G, Orr B, Grace OC, Chan R, Ashley GR, Williams K, Franco OE, Hayward SW & Thomson AA 2007 Transcriptional profiling of inductive mesenchyme to identify molecules involved in prostate development and disease. Genome Biology 8 R213. (doi:10.1186/gb-2007-8-10-r213)
140. Verona EV, Elkahloun AG, Yang J, Bandyopadhyay A, Yeh IT & Sun LZ 2007 Transforming growth factor-βsignaling in prostate stromal cells supports prostate carcinoma growth by up-regulating stromal genes related to tissue remodeling. Cancer Research 67 5737-5746. (doi:10.1158/0008-5472.CAN-07- 0444)
141. de Visser KE & Coussens LM 2006 The inflammatory tumor microenvironment and its impact on cancer development. Contributions to Microbiology 13 118-137. (doi:10.1159/000092969)
142. de Visser KE, Korets LV & Coussens LM 2005 De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7 411-423. (doi:10.1016/j.ccr.2005.04.014)
143. Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB & Sporn MB 1987 Transforming growth factor type β induces monocyte chemotaxis and growth factor production. PNAS 84 5788-5792. (doi:10.1073/pnas. 84.16.5788)
144. Wakefield LM & Roberts AB 2002 TGF-β signaling: positive and negative effects on tumorigenesis. Current Opinion in Genetics & Development 12 22-29. (doi:10.1016/S0959-437X(01)00259-3)
145. Wang ZA & Shen MM 2011 Revisiting the concept of cancer stem cells in prostate cancer. Oncogene 30 1261-1271. (doi:10.1038/onc.2010.530)
146. Wright JL, Lin DW & Stanford JL 2012 Circumcision and the risk of prostate cancer. Cancer 118 4437-4443. (doi:10.1002/cncr.26653)
147. Yanagisawa N, Li R, Rowley D, Liu H, Kadmon D, Miles BJ, Wheeler TM & Ayala GE 2007 Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy. Human Pathology 38 1611-1620. (doi:10.1016/j.humpath.2007.04.008)
148. Yang L & Moses HL 2008 Transforming growth factor β: tumor
149. Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD & Rowley DR 2005 Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Research 65 8887-8895. (doi:10.1158/0008-5472.CAN-05-1702)
150. Yang F, Strand DW & Rowley DR 2008a Fibroblast growth factor-2 mediates transforming growth factor-β action in prostate cancer reactive stroma. Oncogene 27 450-459. (doi:10.1038/sj.onc.1210663)
151. Yang L, Huang J, Ren X, Gorska AE, Chytil A, Aakre M, Carbone DP, Matrisian LM, Richmond A, Lin PC et al. 2008b Abrogation of TGF β signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 13 23-35. (doi:10.1016/j.ccr.2007.12.004)
152. Yu S, Yeh CR, Niu Y, Chang HC, Tsai YC, Moses HL, Shyr CR, Chang C & Yeh S 2012 Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblasts. Prostate 72 437-449. (doi:10.1002/pros.21445)
153. Zardo G, Cimino G & Nervi C 2008 Epigenetic plasticity of chromatin in embryonic and hematopoietic stem/progenitor cells: therapeutic potential of cell reprogramming. Leukemia 22 1503-1518. (doi:10.1038/leu.2008.141)
154. Zavadil J, Haley J, Kalluri R, Muthuswamy SK & Thompson E 2008 Epithelial-mesenchymal transition. Cancer Research 68 9574-9577. (doi:10.1158/0008-5472.CAN-08-2316)
155. Zeisberg EM & Kalluri R 2010 Origins of cardiac fibroblasts. Circulation Research 107 1304-1312. (doi:10.1161/CIRCRESAHA.110.231910)
156. Zeisberg EM, Potenta S, Xie L, Zeisberg M & Kalluri R 2007 Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Research 67 10123-10128. (doi:10.1158/0008-5472.CAN-07-3127)
157. Zhao H & Peehl DM 2009 Tumor-promoting phenotype of CD90hi prostate cancer-associated fibroblasts. Prostate 69 991-1000. (doi:10.1002/pros.20946)
158. Zhu B & Kyprianou N 2005 Transforming growth factor β and prostate cancer. Cancer Treatment and Research 126 157-173.
159. Zubair AC, Silberstein L & Ritz J 2002 Adult hematopoietic stem cell plasticity. Transfusion 42 1096-1101. (doi:10.1046/j.1537-2995.2002.00156.x)
160. Zynger DL & Yang X 2009 High-grade prostatic intraepithelial neoplasia of the prostate: the precursor lesion of prostate cancer. International Journal of Clinical & Experimental Pathology 2 327-338.